The short explanation
Follow-up after testicular cancer is long because, although treatment is very effective, the cancer can sometimes return, most often within the first few years. Regular blood tests for tumour markers, scans and examinations are designed to catch any return early, when it is still highly treatable. Many men who have a recurrence are still successfully treated. The schedule usually becomes less frequent as time passes. Follow-up also lets your doctor check the remaining testicle, your hormone levels and any long-term effects of chemotherapy or radiotherapy if you had them.
What depends on your situation
The parts of this that change from person to person. Uncertainty is stated, not hidden.
- If you hope to have children, follow-up visits are a good time to discuss semen analysis and fertility, especially if you had chemotherapy.
- Checking the remaining testicle yourself regularly is important, as there is a small chance of a new cancer on the other side.
- Keeping copies of your reports and treatment summary helps if you move or change doctors.
What this answer cannot determine
The boundary of online education. These need a clinician who can see you.
- This cannot tell what your follow-up schedule should be or your risk of recurrence. Your oncologist or urologist can explain that based on your cancer type and treatment.
Questions for your clinician
Take these with you. You can add any of them to an appointment card.
- How often will I need scans and blood tests, and for how long?
- What is my risk of the cancer returning?
- Can my fertility be checked now?
- Are there long-term effects of my treatment I should know about?
When to seek help
Clinician-approved guidance for this topic. When in doubt, being seen is never the wrong choice.
Emergency — call 112 now
- Call 112 if you develop sudden chest pain, severe breathlessness or coughing up blood.
Raise it at a routine appointment
- Keep all scheduled follow-up appointments and tests.
Sources
The evidence this explanation is built on.
- Testicular cancer National Cancer Institute (NIH)
- Testicular cancer NHS
Who wrote and reviewed this
Every AskHim answer names its author. A clinically reviewed answer also names the clinician who signed it off — if no clinician is named below, it has not been clinically reviewed.
- Author
- AskHim Editorial (AI-assisted)
- Clinical reviewer
- Nobody yet No clinician has signed this answer off. That is what the “Editorially reviewed” badge means, and why it does not say “Clinically reviewed”. It was written and checked by AskHim’s editorial team against the sources listed above, and it is queued for a clinician who works in this area.
- Review status
- Editorially reviewed
- Last reviewed
- Last reviewed 11 November 2026
- Version
- 1
Correction history
Substantive changes are listed, not quietly edited away.
No corrections have been made since this answer was first published.
Did this answer your question?
Whatever you choose is filed against this version of the answer, never against you, and it is never shown as a count.
“Explain more simply” asks which part was hard to follow, so the author knows what to rewrite. “My question is different” tells the editorial team this answer missed your point, then lets you ask your own question privately. Nothing about you is sent with either.
Saving, following up and reporting are all private. Nothing you do on this page is visible to other readers or to the doctor who wrote it, unless you ask a question.